Company intelligence / Profile preview

Autolomous

London, Greater London, United Kingdomautolomous.com ↗

Ownership: Private
Development stage: Other

Overview

No direct clinical results since it does not develop therapeutics. The platform enables improved batch record digitization, integration with facility systems/technologies, enhanced data visibility leading to streamlined compliance response times, shorter investigation timelines, reduced costs of goods sold (COGS), higher productivity and scalability in CGT manufacturing.

Modalities: Digital platform solutionsSoftware solutions
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Center for Breakthrough Medicines (CBM)

Beyond the preview

Go deeper on Autolomous.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autolomous.

Explore the full profile